Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Rocuronium vs Succinylcholine for RSI
NCT04709315Phase 3Unknown
- Sponsor
- South Valley University
- Start
- Oct 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of rocuronium and dexmedetomidine in tracheal intubation (2 arms), sponsored by South Valley University. Primary endpoint: number of patients with excellent intubating conditions. Status: unknown.
02
Drugs
rocuroniumdexmedetomidine
03
Conditions
tracheal intubation
Beyond the preview
Go deeper on NCT04709315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04709315.